Latest filing published 27 Dec 2023 for POINT Biopharma Global Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Allan C. Silber is a declared insider at 2 companies (board member); the most frequent names are Heritage Global Inc. and POINT Biopharma Global Inc. Between 11 March 2021 and 22 December 2023, the trades on record add up to 11 filings.
Market trades split into 1 purchase (€159k) and 7 sales (€447k). Netting one side against the other leaves €287k of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant.
On 27 December 2023 came the latest disclosure, a transaction in POINT Biopharma Global Inc. The last insider purchase was made public on 21 November 2022, 1,427 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations